Condition: Type 2 Diabetes Mellitus (T2DM) · Sponsor: University Hospital, Ghent
This cross-sectional study seeks to characterize the overall polyphenol metabotype in patients with T2DM in comparison to age-matched individuals without diabetes. Additionally, the study aims to identify factors that influence the polyphenol metabotype (transit time and gut microbial capacity to degrade polyphenols in particular).
This description comes directly from the study's public registry record.
Jan Stautemas, PhD · 003293328967 · jan.stautemas@ugent.be
Patrick Calders, Professor · patrick.calders@ugent.be
Always discuss trial participation with your own doctor first.
| Ghent University | Ghent, East Flanders, Belgium | Not Yet Recruiting |
| Department of rehabilitation sciences - UGent | Ghent, Belgium | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06810635